Skip to main content
Premium Trial:

Request an Annual Quote

Macrogen Uses ABI Array Tech to Provide Gene Expression Services to Korean Regulators

NEW YORK, Aug. 10 (GenomeWeb News) - Macrogen of Korea will provide gene expression-analysis services to the Korean National Institute of Toxicological Research using microarray technology from Applied Biosystems, the companies said yesterday.

 

Researchers at NITR, which operates under the Korean Food and Drug Administration, will use ABI's Expression Array system to develop predictive gene signatures and toxicology evaluation technology for food and drugs, including traditional herbal medicines.

 

The project complements other studies by NITR, such as a genomic and proteomic expression database for unidentified toxic substances, herbal medicines, and biotechnological product evaluation. The aim of the studies is to standardize food and drug safety measurements and to establish evaluation criteria.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.